- Trials with a EudraCT protocol (9)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
9 result(s) found for: Immunopathology.
Displaying page 1 of 1.
EudraCT Number: 2010-023185-42 | Sponsor Protocol Number: S105AMCNilotinibSpA | Start Date*: 2011-04-21 |
Sponsor Name:Academic Medical Center, Division of Clinical Immunology and Rheumatology | ||
Full Title: Proof-of-concept double-blind, placebo-controlled, randomized clinical trial with nilotinib in spondyloarthritis | ||
Medical condition: Active axial and peripheral spondyloarthritis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-002339-24 | Sponsor Protocol Number: NA | Start Date*: 2012-05-25 |
Sponsor Name:Barts and the London NHS Trust | ||
Full Title: Open label, single-centre study to evaluate the efficacy of the bradykinin (BK) B2 receptor antagonist, Icatibant, in the relief of symptoms resulting from moderate to severe angioedema unresponsiv... | ||
Medical condition: Idiopathic Angioedema | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-007180-16 | Sponsor Protocol Number: RITIS | Start Date*: 2009-05-13 | |||||||||||
Sponsor Name:LUMC | |||||||||||||
Full Title: INFLUENCE OF B CELL DEPLETION BY MONOCLONAL ANTI-CD20 ANTIBODIES IN SYSTEMIC SCLERODERMA | |||||||||||||
Medical condition: systemic sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001874-32 | Sponsor Protocol Number: RDC-CNGA3-01 | Start Date*: 2015-09-09 | |||||||||||
Sponsor Name:Universitätsklinikum Tübingen | |||||||||||||
Full Title: Safety and efficacy of a bilateral single subretinal injection of rAAV.hCNGA3 in adult and minor patients with CNGA3-linked achromatopsia investigated in a randomized, wait list controlled, observe... | |||||||||||||
Medical condition: CNGA3-linked achromatopsia | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-017306-36 | Sponsor Protocol Number: TIGER | Start Date*: 2010-11-19 | |||||||||||
Sponsor Name:Leiden University Medical Center, Department of Rheumatology | |||||||||||||
Full Title: ANTI-IGE THERAPY (OMALIZUMAB) IN IGE-ACPA POSITIVE RA. | |||||||||||||
Medical condition: RHEUMATOID ARTHRITIS | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004042-41 | Sponsor Protocol Number: D5890C00003 | Start Date*: 2005-05-18 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A comparison of the inflammatory control of asthma provided by one inhalation of Symbicort® Turbuhaler® 160/4.5 µg/inhalation b.i.d. plus as-needed versus one inhalation of Symbicort® Turbuhaler® 3... | |||||||||||||
Medical condition: This is a Phase IIIB trial to be conducted in adult asthmatic patients. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) SE (Completed) GB (Completed) ES (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004598-83 | Sponsor Protocol Number: 54371254 | Start Date*: 2008-10-22 | |||||||||||
Sponsor Name:EBMT (European group for Blood and Marrow Transplantation) | |||||||||||||
Full Title: High dose immunoablation and autologous hematopoietic stem cell transplantation versus monthly intravenous pulse therapy cyclophosphamide in severe systemic sclerosis ( ‘ASTIS’-TRIAL: Autologous S... | |||||||||||||
Medical condition: Severe systemic sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003520-20 | Sponsor Protocol Number: R668-BP-1902 | Start Date*: 2020-05-19 | |||||||||||
Sponsor Name:Regeneron Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients with Bullous Pemphigoid | |||||||||||||
Medical condition: Bullous pemphigoid (BP) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) DE (Trial now transitioned) PL (Trial now transitioned) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004718-32 | Sponsor Protocol Number: NL72607.041.20 | Start Date*: 2020-10-09 |
Sponsor Name:UMC Utrecht | ||
Full Title: Upfront autologous hematopoietic stem cell transplantation versus immunosuppressive medication in early diffuse cutaneous systemic sclerosis: an international multicentre, open-label, randomized co... | ||
Medical condition: Diffuse cutaneous systemic sclerosis according to the ACR/EULAR criteria | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) IT (Trial now transitioned) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
